BMC Medical Co., Ltd. Share Price

Equities

301367

CNE100005WQ4

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. 03:30:00 10/05/2024 am IST 5-day change 1st Jan Change
88.03 CNY -1.49% Intraday chart for BMC Medical Co., Ltd. -2.48% -27.70%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 122.5Cr 17Cr 1.41TCr Sales 2025 * 158.25Cr 22Cr 1.83TCr Capitalization 563.39Cr 78Cr 6.5TCr
Net income 2024 * 31Cr 4.27Cr 356.54Cr Net income 2025 * 44Cr 6.14Cr 512.31Cr EV / Sales 2024 * 4.6 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 3.56 x
P/E ratio 2024 *
18.3 x
P/E ratio 2025 *
12.7 x
Employees 878
Yield 2024 *
-
Yield 2025 *
-
Free-Float 29.54%
More Fundamentals * Assessed data
Dynamic Chart
BMC Medical Co., Ltd. Approves Cash Dividend for the Year 2023 CI
BMC Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
BMC Medical Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI
BMC Medical Plans Buyback of Up to 60 Million Yuan Shares MT
BMC Medical Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. CI
BMC Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BMC Medical Co., Ltd. authorizes a Buyback Plan. CI
BMC Medical Co., Ltd. and Zhuhai Shunxing Management Consulting Partnership Enterprise (Limited Partnership) agreed to acquire an unknown minority stake in Shenzhen Dedaxing Drive Technology Co., Ltd. from Shenzhen Dedaxing Technology Partnership Enterprise (Limited Partnership), Liu Dong, Yang Zhu, Zhang Zhenjian, Sang Quan, and Chen Xianqi for CNY 55.2 million. CI
Shenzhen Dedaxing Drive Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from BMC Medical Co., Ltd., Zhuhai Shunxing Management Consulting Partnership Enterprise (Limited Partnership) CI
Certain A Shares of BMC Medical Co., Ltd. are subject to a Lock-Up Agreement Ending on 1-NOV-2023. CI
BMC Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
BMC Medical Co., Ltd.(XSEC:301367) added to S&P Global BMI Index CI
BMC Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
BMC Medical Co., Ltd. Approves Board Changes CI
BMC Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
1 day-1.49%
1 week-2.48%
Current month-2.48%
1 month+1.35%
3 months-14.39%
6 months-20.46%
Current year-27.70%
More quotes
1 week
87.10
Extreme 87.1
93.87
1 month
71.50
Extreme 71.5
93.87
Current year
71.50
Extreme 71.5
122.88
1 year
71.50
Extreme 71.5
226.00
3 years
71.50
Extreme 71.5
333.88
5 years
71.50
Extreme 71.5
333.88
10 years
71.50
Extreme 71.5
333.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/13/01
Founder 55 27/01/27
Director of Finance/CFO 51 01/16/01
Members of the board TitleAgeSince
Director/Board Member 46 01/11/01
Director/Board Member 59 01/18/01
Director/Board Member 59 01/18/01
More insiders
Date Price Change Volume
10/24/10 88.03 -1.49% 485,747
09/24/09 89.36 +0.35% 632,522
08/24/08 89.05 -2.25% 539,300
07/24/07 91.1 +2.06% 754,600

End-of-day quote Shenzhen S.E., May 10, 2024

More quotes
BMC Medical Co Ltd is a China-based company mainly engaged in the manufacture of medical equipment and consumable products in the field of respiratory health. The Company's products mainly include non-invasive home ventilators, ventilation masks, sleep monitors and high-flow humidified oxygen therapy devices. The Company also provides respiratory health chronic disease management services. The Company focuses on the treatment of patients with sleep apnea-hypopnea syndrome (SAHS), mainly obstructive sleep apnea syndrome (OSA), as well as patients with respiratory insufficiency, mainly chronic obstructive pulmonary disease (COPD), providing a full-cycle and multi-scenario overall solution for treatment services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
88.03 CNY
Average target price
120.9 CNY
Spread / Average Target
+37.38%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301367 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW